Business Context and Reporting Period
This Form 8-K filing by AAR CORP. was submitted on July 10, 2007, reporting corporate governance and shareholder rights events occurring on that date. The company is incorporated in Delaware and operates from Wood Dale, Illinois.
Key Financial Metrics
This filing is a current report regarding corporate actions and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. No financial metrics are provided in this document.
Material Changes and Corporate Actions
- Poison Pill Implementation: The Board declared a dividend of one Right for each outstanding share of Common Stock to stockholders of record on August 6, 2007. These Rights replace those distributed in 1997.
- Right Terms: Each Right entitles the holder to purchase one share of Common Stock at a purchase price of $140 per share, subject to adjustment. The Rights expire on August 6, 2017, unless earlier redeemed.
- Trigger Mechanisms: The Rights become exercisable upon a "Distribution Date," triggered if a person or group acquires 15% or more of the outstanding Common Stock (an "Acquiring Person") or announces a tender offer resulting in such acquisition.
- Flip-In and Flip-Over Provisions: If an Acquiring Person is identified, non-acquiring holders may exercise Rights to receive shares with a market value of two times the exercise price. Similar provisions apply in the event of a merger or asset sale.
- Redemption: The Company may redeem the Rights at $0.01 per Right at any time prior to the tenth day after an Acquiring Person is identified.
- Board Election: Timothy J. Romenesko, currently President and Chief Operating Officer, was elected to the Board of Directors and named to the Executive Committee.
- Bylaw Amendment: The Company amended its Bylaws to allow stockholder interests to be evidenced by either certificate or book entry (electronic) form, whereas previously only certificates were permitted.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future performance, or specific risk factors beyond the mechanics of the Rights Agreement. The primary contingency described is the potential dilution of an Acquiring Person's stake through the Flip-In and Flip-Over provisions if a hostile takeover attempt occurs.
Investor Verification Checklist
- Verify the Record Date of August 6, 2007, to determine eligibility for the Rights dividend.
- Confirm the current market price of AAR CORP. Common Stock relative to the $140 exercise price of the Rights.
- Review the full Rights Agreement (Exhibit 4.1) for specific adjustment formulas and exceptions to the 15% trigger threshold.
- Monitor for any public announcements regarding beneficial ownership exceeding 15% which would trigger the Distribution Date.
- Check subsequent filings for any Board decisions to redeem the Rights at the $0.01 price.